OMENN GILBERT S 4
4 · GALECTIN THERAPEUTICS INC · Filed Jan 27, 2025
Insider Transaction Report
Form 4
OMENN GILBERT S
Director
Transactions
- Award
Stock Option (right to buy)
2025-01-23+60,000→ 60,000 totalExercise: $1.23Exp: 2035-01-23→ Common Stock (60,000 underlying)
Footnotes (2)
- [F1]The stock options were issued pursuant to the Galectin Therapeutics, Inc. 2019 Omnibus Equity Incentive Plan.
- [F2]The options vest 100% on December 31, 2025.